StockNews.AI
ANGO
StockNews.AI
139 days

AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial Results

1. AngioDynamics announces Q3 fiscal 2025 financial results with significant year-over-year growth.

Earnings
+6.47%Current Return
VS
-2.79%S&P 500
$9.6604/02 06:35 AM EDTEvent Start
$10.28504/03 12:42 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

Strong financial performance often leads to positive market sentiment, similar to past earnings reports boosting stock prices.

How important is it?

Improved financial performance can attract investors, impacting stock valuation positively.

Why Short Term?

Immediate financial results may lead to investor interest and short-term stock movements.

Related Companies

SNNMASIMDT
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the third quarter of fiscal year 2025, which ended February 28, 2025. Fiscal Year 2025 Third Quarter Highlights   Quarter Ended February 28, 2025 Pro Forma* YoY Growth Pro Forma* Net Sale.

Related News